RedHill Biopharma Awarded $733K U.S. HHS BARDA Contract To Investigate Opaganib As Host-Directed Therapeutic For Ebola Virus Disease
RedHill Biopharma Awarded $733K U.S. HHS BARDA Contract To Investigate Opaganib As Host-Directed Therapeutic For Ebola Virus Disease
redhill biopharma獲得73.3萬美元HHS BARDA合同，調查Opaganib作爲針對埃博拉病毒疾病的宿主定向治療
RedHill Biopharma Awarded $733K U.S. HHS BARDA Contract To Investigate Opaganib As Host-Directed Therapeutic For Ebola Virus Disease
redhill biopharma獲得73.3萬美元HHS BARDA合同，調查Opaganib作爲針對埃博拉病毒疾病的宿主定向治療
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間